Volitionrx Stock In The News

VNRX Stock  USD 0.63  0.02  3.28%   
Our overall analysis of Volitionrx's news coverage and content from conventional and social sources shows investors' bearish mood towards Volitionrx. The specific impact of Volitionrx news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Volitionrx's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Volitionrx headlines in addition to utilizing other, more conventional financial analysis modules. Check out Volitionrx Backtesting and Volitionrx Hype Analysis.
For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Volitionrx Today Top News and Investor Outlook

Yahoo News
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriters
https://finance.yahoo.com/news/volitionrx-limited-announces-exercise-over-201000922.html
 Neutral
Yahoo News
VNRX: Highlights of Capital Markets Day ...
https://finance.yahoo.com/news/vnrx-highlights-capital-markets-day-100000730.html
 Neutral
Yahoo News
VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock
https://finance.yahoo.com/news/volitionrx-limited-announces-closing-16-201000903.html
 Neutral
Yahoo News
VolitionRx Limited Announces Pricing of $16.5 Million Underwritten Public Offering of Common Stock
https://finance.yahoo.com/news/volitionrx-limited-announces-pricing-16-131500329.html
 Neutral
Yahoo News
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
https://finance.yahoo.com/news/volitionrx-limited-announces-proposed-underwritten-200100259.html
 Neutral
Yahoo News
Volition Study shows Nucleosome Concentrations are a useful tool for Canine Cancer Treatment Monitoring
https://finance.yahoo.com/news/volition-study-shows-nucleosome-concentrations-110000895.html
 Neutral
Yahoo News
VolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update
https://finance.yahoo.com/news/volitionrx-limited-announces-first-quarter-201000090.html
 Neutral
Yahoo News
VolitionRx Limited Schedules First Quarter 2023 Earnings Conference Call and Business Update
https://finance.yahoo.com/news/volitionrx-limited-schedules-first-quarter-120000206.html
 Neutral
Yahoo News
VolitionRx Limited to Host Capital Markets Day at the NYSE on Thursday May 11.
https://finance.yahoo.com/news/volitionrx-limited-host-capital-markets-113000546.html
 Neutral
Yahoo News
Keynotes, Educational Panels and 77 Comp...
https://finance.yahoo.com/news/keynotes-educational-panels-77-companies-130000939.html
 Bullish

Volitionrx Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Volitionrx and other traded companies coverage with news coverage. We help investors stay connected with Volitionrx headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on Volitionrx Stock performance. Please note that trading solely based on the Volitionrx hype is not for everyone as timely availability and quick action are needed to avoid losses.
Volitionrx's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Volitionrx investors visualize upcoming and past events in order to time the market based on Volitionrx noise-free hype analysis.
Volitionrx stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Volitionrx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Volitionrx that are available to investors today. That information is available publicly through Volitionrx media outlets and privately through word of mouth or via Volitionrx internal channels. However, regardless of the origin, that massive amount of Volitionrx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Volitionrx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Volitionrx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Volitionrx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Volitionrx alpha.

Volitionrx Largest EPS Surprises

Earnings surprises can significantly impact Volitionrx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-14
2024-06-30-0.09-0.080.0111 
2021-03-22
2020-12-31-0.1-0.11-0.0110 
2023-11-14
2023-09-30-0.13-0.110.0215 
2023-03-15
2022-12-31-0.15-0.130.0213 
2021-11-10
2021-09-30-0.11-0.13-0.0218 
2021-08-11
2021-06-30-0.12-0.10.0216 
View All Earnings Estimates

Volitionrx Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Volitionrx Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
29th of January 2025
VolitionRxs Buy Rating Reiterated at D. Boral Capital - MarketBeat
at news.google.com 
Google News at Macroaxis
6th of January 2025
StockNews.com Begins Coverage on VolitionRx - MarketBeat
at news.google.com 
Investing News at Macroaxis
10th of December 2024
VolitionRx CEO Cameron John Reynolds acquires 79,999 in stock
at investing.com 
news
6th of December 2024
VolitionRx Pioneering Epigenetic Diagnostics
at kalkinemedia.com 
Google News at Macroaxis
20th of November 2024
VolitionRx Limited Reports Earnings Results for the Third Quarter and Nine Months Ended Se...
at news.google.com 
Gurufocus Stories at Macroaxis
15th of November 2024
Armistice Capital, LLC Acquires New Stake in VolitionRX Ltd
at gurufocus.com 
Gurufocus Stories at Macroaxis
14th of November 2024
VolitionRX Ltd Q3 2024 Earnings Report Preview What to Look For
at gurufocus.com 
Google News at Macroaxis
8th of November 2024
VolitionRx Sets Q3 2024 Earnings Call Key Executives to Present Financial Results VNRX Sto...
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Volitionrx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Volitionrx's short interest history, or implied volatility extrapolated from Volitionrx options trading.

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.